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Abstract 
Background: According to an International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence of asthma in children 
of 6-7 years old has increased by 10%, and at the age of 13-14 years by 16% over the last decade. Determining the factors that are 
keys to the occurrence of the disease and its severity is important in explaining the pathogenesis of bronchial asthma. 
Methods: Analyzed 142 indicators of clinical and paraclinical examination of 70 children with asthma. To select factors that could be 
significant in the formation of severe asthma, applied the method of logistic regression with step-by-step inclusion of predictors. Both 
quantitative and qualitative characteristics were selected. Each qualitative attribute was coded “1” if the child had this characteristic, 
or “0” if this characteristic had not been established. The formation of a severe asthma course was accepted according to (1) and the 
absence of a severe asthma flow formation as (0).  
Results: Analyzed the model of paired regression, the boundary value of thymic stromal lymphopoietin was established, exceeding 
which indicates the high probability of the presence of severe bronchial asthma. Increasing the value of thymic stromal lymphopoietin 
by 10 pg/mL suggests an increase in the likelihood of severe asthma by 10%. 
Conclusions: A complex of steam regression models has been developed to determine the factors characterizing the severity of 
bronchial asthma. The risk of developing severe bronchial asthma in children has been determined and 15 factors have been identified 
that affect severe asthma. 
Keywords: asthma, child, matched-pair analysis, thymic stromal lymphopoietin 
 
 
 
Introduction 
Nowadays, there are 339 million people suffering from bronchial asthma in the world [1]. Despite many years of research, asthma is still 
the most common chronic disease within the children population in different countries of the world, and the incidence increases with every 
passing year [2].  Asthma remains one of the most common causes of disability in pediatric ages and takes the 4th place in the structure  
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of common disabilities among 10-14 years old children [3-5]. Patients' quality of life significantly decreases and is followed by notable 
economic expenditures both for the family and for the society [6]. The first symptoms of the disease often appear in childhood and it is 
still difficult to prognosticate further course of the disease. Prognostication of asthma course and disease in children is still a difficult 
problem, because of the multifactority of the disease [7]. Numerous clinical studies of uncontrolled asthma course approve the necessity 
to analyze the factors influencing severe forms of the disease [8-10]. One such factor can be thymic stromal lymphopoietin (TSLP). There 
is a relationship between TSLP dysregulation and its role in the pathogenesis of atopic diseases, such as atopic dermatitis, asthma, 
allergic rhinitis and eosinophilic esophagitis [11,12]. Detection of cases at early stages with the risk of severe asthma development in 
children is one of the main problems. This gives us the opportunity to use individual methods of therapy and observation in these cases. 
Selection and substantiation of regression models which define the characterizing severity of bronchial asthma are the aims of the study.  
 
Methods 
Let's take a look at the method of construction of the complex of regressive models containing K number of inputs (regressors) ,  
( ) and M number of outputs , ( ). 
Let’s present the dependence of the inputs and outputs in this form 
 
where -    is a random error. The random error is determined by the fact that measured experimental values of inputs and outputs 
deviate from its initial values due to random errors. We will construct the regressive model for the case when the random error in the 
equation of regression  is subject to the normal distribution law.  
Let’s assume that after examining of i-patient parameter will equal , ( ). Value of equals to . 
 
which is distributed by the normal law with the mathematical expectation 
 
and standard deviation 
, 
that characterizes the error of measurement. Let’s assume that values of the factors obtained after examining every particular i-patient 
(clinical examining data) were received with the same accuracy that allows us to write  
. 
Then probability distribution of  can be presented as 
.    (2) 
The probability that the value of output  for i-patient is in this range   can be calculated with the following 
equation 
. 
Since the events under which  factor equals  are independent then the possibility that values    of the explained factor 
 for the first patient lays within , for the second patient lays within ,…, for N-patient 
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. (4) 
Let’s determine the average so that expression (4) would comply with the maximum value. In 
view of the fact that 
 
.  (5) 
It follows that the possibility (4) will be maximal if the sum of the squares of errors is minimal 
 .  (6) 
Expression (6) complies with the fact that there are two dependencies , for which the set of 
experimental values  of the output parameter is the most possible. Emphasize that the values of factors determined after 
examination of every particular i-patient were received with the same accuracy. In another case expression (6) should be written in this 
form 
.   
The function  can be depicted as a superposition Z of known functions 
 
with  coefficients, that are derived from the case (6) 
 
where                
                . 
Let’s show the received system of equations in the following form 
.     (8) 
Unknown coefficients are determined by the solution of the system of linear equations (8) with the defined system of functions 
 which is in many cases an orthogonal system of functions on the interval of changes of values of the 
parameters . In that regard let’s present the dependence  as an orthogonal range of Wiener [13]:  
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This submission allows expressing coefficients at functions  through initial moments of random errors
. Define the values , at which the left side of the expression (6) accepts the minimal value. For this 
we find extreme value for expression (6) regarding the rates  with the dependence of input and output factors 
(9): 
           ,                 (10) 
, 
, 
Differentiate the function  respectively on ,  obtain 
,  ,   .  (11) 
Substitute the values of partial derivatives (11) of the function  into the system of equations (10), we 
obtain the system of equations for identification of unknown rates : 
 ,                (12) 
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 (14) 
In case of selection of linear relationship for parameters  expression (9) become  
 
with the value of coefficients a and , that are determined by the system of equations (14): 
 
Using the definition of dispersion and covariance of a random variable 
,   (15) 
, 
the expression for coefficients a and  can be presented as 
, , 
that determines the equation of the model of matched regression 
.  (16) 
Increasing of covariance rate via the absolute value leads to enhancement of the dependence between  and  parameters. If we 
turn to dimensionless variables 
,  ,   (17) 
we obtain a dimensionless equation of model of couple regression 
,  ,   ,  (18) 
that looks more compact comparing to (16). The correlation coefficient between factors  and , characterizes the degree of 
the linear relationship between them. The module of value  defines the degree of density of linear relationship. For the factors 
which acquire non-random values, . Equality means that there is no linear relationship between factors  and 
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Unprocessed data of experimental research are presented in [14]. The study respects for human rights in accordance with the current 
legislation of Ukraine, follows international ethical requirements and does not violate any scientific ethical norms as well as standards of 
biomedical research. Individual data of the patients are encoded. Before the experiment conduction, factors that could affect the severity 
of bronchial asthma are identified. The following 142 factors are categorized [Table 1], allowing to unify the data analysis and structure 
the relationships between them [15] [Figure 1–6]. 
 
Table 1. Classification of factors [2] 
№ Name Common information 
1 Course type Severe persistent, moderate persistent, mild persistent, intermittent 
2 Principal 
diagnosis  
(case taking) 
Allergic rhinitis, atopic dermatitis, deflection of the nasal septum, secondary cardiomyopathy 
3 Anamnesis of 
disease 
Number of years from the first symptoms 
4 Anamnesis of life Bronchial asthma in mother, allergic rhinitis in mother, bronchial asthma in father, allergic rhinitis in 
father, bronchial asthma in relatives of the second generation 
5 Complete blood 
count 
RBC, HBC, WBC, eosinophils%, basophils%, band neutrophils%, segmented neutrophils%, 
lymphocytes%, monocytes%, ESR 
6 Urinalysis test Color, appearance, specific gravity, pH, leukocytes, transitional epithelial cells, mucus 
7 Skin allergy test 
(pollen allergens) 
Chenopodium, birch, sagebrush, sunflower, timothy, cock's-foot, rye, elytrigia, ryegrass, alder, fescue 
grass, walnut, linden, plantain, nettle, dandelion, sumpweed, foxtail, ragweed, chestnut, cypress, maple 
8 Skin allergy test 
(household 
allergens) 
Domestic dust, pillow feather, daphnia, rabbit hair, cat hair, dog hair, sheep wool 
9 Food allergy test Egg white, carp fish, pollack fish, milk, lemon, apple, raspberries, beetroot, cabbage, beef, pork, chicken, 
banana, watermelon, orange, tangerine, grape, cocoa, soybeans, black tea, tomato, beans, rice groats, 
buckwheat grits, wheat groats, oat grits, corn grits, rye grits 
10 Ig E Serum immunoglobulin E 
11 Spirogram VC, FVC, PEF, FEF(MEF) 25%, FEF(MEF) 50%, FEF(MEF) 75%, FEV 25-75%, FEV1, FEV/FVC %, 
MVV. 
12 Immunological 
status 
Leukocytes, neutrophils (%;103 cells), lymphocytes (%;103 cells), CD3 (%;103 cells), CD4 (%;103 cells), 
CD8 (%;103 cells), CD16 (%;103 cells), CD22 (%;103 cells), CD25 (%;103 cells), IgA, IgM, IgG, 
phagocytosis of latex, %, phagocytic number, total complement (СН 50), CIC with 3.5% PEG, units., 
spontaneous NBT tests, %, spontaneous IAN tests, units., stimulated NBT test, %, stimulated IAN test, 
units, lysosomal cationic proteins, units 
13 TSLP The level of serum thymic stromal lymphopoietin  
14 Age Age of the examined children from 6 to 17 years 
15 Gender Surveyed 56 boys and 14 girls 
 
A large number of factors that determine the presence of a certain sign are coded with 0 or 1 (e.g. [4. Bronchial asthma in mother]=1, if 
this sign characterizes the patient and [4. Bronchial asthma in mother]=0, if the sign is absent). There are factors in the analysis above 
that can accept values related to several situations. For instance, factor [8. Pillow feather], Figure 6, characterizing the degree of intensity 
of a diagnostic skin test is coded so every degree of intensity relates to a certain number. ([8. Pillow feather]=0 if the sign is absent,  [8. 
Pillow feather]=1 or 2 if the reaction is weakly positive, 3 and 4 if it is positive. Factor [8. Domestic dust] also relates to such kind of factors 
(0- if there is no reaction to dust, 1 and 2 – mild reaction, 3 and 4 – positive, Figure 2). Factors that can turn continuous variables after 
measurement are characterized by the unit of measurement ([3. Number of years from the first symptoms], [12. CD8 10*3 cells]), [13. 
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TSLP], [Figure 1-4] [14]. The number before the name of the factor determines the category to which this factor relates to, (Table 1: TLSP 
factor, category №13) [15]. 
Factors that were identified after clinical examination in not more than two patients were excluded from the input unprocessed data [Table 
2]. The list of excluded factors is in Table 2. It’s expected that excluded factors don’t affect the result of the research too much so they 
can be omitted. It allowed shortening the number of factors for analysis by ~10%. So, 130 factors were used for the regressive model.  
 
Table 2. List of excluded factors [15] 
№ Name The number of patients with 
the present factor 
Description of the category of factor [Table 1] 
1 Vasomotor rhinitis 2 2. Principal diagnosis (case taking) 
2 Allergic rhinosinusitis 2 
3 Corn 2 7. Skin allergy test (pollen allergens) 
 4 Acacia 2 
5 Willow 1 
6 Sorrel 2 
7 Hazel 2 
8 Egg yolk 2 9. Food allergy test 
 9 Hake 2 
10 Cucumber 2 
11 Carrot 2 
12 Potatoes 2 
 
The next step of the research was dividing the data into two different parts. The first part was used for the construction of the regressive 
model [16], the second part – the testing one, for verification of the regressive model adequacy. 
 
Results and Discussion 
Conducted literature review characterizes bronchial asthma as a heterogeneous disease with an increasing number of severe cases [17-
19]. Numerous clinical research of low-controlled severe bronchial asthma confirms the necessity of studying new biological markers for 
appropriate therapy onset [20]. For understanding the pathophysiology of severe bronchial asthma, the analysis of factors affecting the 
beginning of severe forms is needed. Severe bronchial asthma will be characterized by explained factors [1. Severe persistent]. We have 
already analyzed the factor “thymic stromal lymphopoietin” [13. TSLP] [21-24], which is used for assessment of the severity of bronchial 
asthma. Its high numbers are usually for severe bronchial asthma [25-27]. Researchers Soumelis [28] and Lee [29] proved the importance 
of TSLP in the pathogenesis of atopic dermatitis. 
The relationship between the researched factors is determined by the correlation coefficient [16], which complies with the level of the 
linear relationship between factors. As a consequence of that, it's advisable to choose a combination of factors for the construction of the 
complex of the models of matched regression those to have both the highest and the lowest values of the correlation coefficient via 
absolute value. The group of factors with the highest value of the correlation coefficient is supposed to have significant relations between 
factors in the model of matched regression. By contrast, a group of factors with the lowest value of the correlation coefficient is supposed 
to have no relations between factors. Both groups are needed for the research. The first group allows defining the set of factors that can 
be used to identify the severity of bronchial asthma. In our research, we assume that there is a relationship between explained factor and 
regressor (the weak relationship is also taken into account), if the correlation coefficient is 
.       (19) 
The full list of factors with the value of the correlation coefficient (19), used for the construction of the model of matched regression is 
given in [16]. The second group of factors is characterized by the absolute value of the correlation coefficient 
.       (20) 
It’s assumed that for this group there is no relationship between the explained factor and the regressor. Such an approach allows us to 
reduce the dimensionality of the model. In our case, it’s only 15 factors out of 130 (including excluded ones) for which the condition is met 
x1y1r 0.21³
x1y1r 0.21<
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(19). Equations of the regressive models for the factors defined by restriction (19) are given in Table 3. The list of factors for which the 
lowest value of the correlation coefficient│ │< 0.02 is given in Table 4. The extended list of factors satisfying the restriction (20) 
is in [16].  
 
Table 3. Complex of the pair regression models 
№ 
 
Explainable 
factor, y1 
Regressor, x1 Regression model (16) 
1 - 0.26 13. TSLP 
 
6. Color 𝑦" = 33.36 − 15.16𝑥" 
2 -0.26 12. CD8 10*3 cells 𝑦" = 60.27 − 44.6𝑥" 
3 -0.24 5. ESR 𝑦" = 39.4 − 3.61𝑥" 
4 0.22 4. Bronchial asthma in relatives of the second 
generation 
𝑦" = 23.75 + 24.67𝑥" 
5 0.25 14. Age 𝑦" = 3.83 + 2.0𝑥" 
6 0.26 2. Allergic rhinitis 𝑦" = 17.9 + 15.16𝑥" 
7 0.28 8. Domestic dust 𝑦" = 9.37 + 7.23𝑥" 
8 0.30 8. Pillow feather 𝑦" = 16.73 + 10.8𝑥" 
9 0.37 2. Atopic dermatitis 𝑦" = 23.03 + 49.04𝑥" 
10 0.40 8. Sheep wool 𝑦" = 15.76 + 17.67𝑥" 
11 0.45 8. Rabbit hair 𝑦" = 16.94 + 15.26𝑥" 
12 0.77 1. Severe persistent  𝑦" = 16.63 + 68.04𝑥" 
1 -0.26 1. Severe 
persistent 
12. CD8 10*3 cells 𝑦" = 0.52 − 0.5𝑥" 
2 -0.25 12. CD 25% 𝑦" = 0.40 − 0.01𝑥" 
3 -0.23 12. CD 25 10*3 cells 𝑦" = 0.29 − 0.24𝑥" 
4 -0.21 10. Ig E 𝑦" = −0.03 + 0.19𝑥" 
5 0.24 8. Rabbit hair 𝑦" = 0.08 + 0.09𝑥" 
6 0.25 5. Eosinophils 𝑦" = 0.03 + 0.02𝑥" 
7 0.32 8. Sheep wool 𝑦" = 0.04 + 0.16𝑥" 
8 0.32 8. Domestic dust 𝑦" = −0.08 + 0.09𝑥" 
9 0.27 7. Foxtail 𝑦" = 0.08 + 0.19𝑥" 
10 0.30 7. Cypress 𝑦" = 0.07 + 0.15𝑥" 
11 0.30 2. Allergic rhinitis 𝑦" = 0.03 + 0.2𝑥" 
12 0.32 3. Number of years from the first symptoms 𝑦" = −0.01 + 0.02𝑥" 
13 0.34 8. Pillow feather 𝑦" = 0.02 + 0.14𝑥" 
14 0.43 2. Atopic dermatitis 𝑦" = 0.1 + 0.65𝑥" 
15 0.77 13. TSLP 𝑦" = −0.09 + 0.01𝑥" 
 
Table 4. Regressors for which lack of connection with the explained factor is assumed 
 № Regressor, x1 № Regressor, x1 
1. 9. Black tea 9. 6. Specific gravity 
2. 6. Appearance 10. 9. Apple 
3. 7. Walnut 11. 7. Sunflower 
4. 9.Cocoa       12. Total complement (СН 50) 12. 6. Transitional epithelial cells 
5. 7. Sagebrush 13. 12. IgA 
6. 12. Lymphocytes, 10*3 cells 14. 8. Daphnia 
7. 2. Deflection of the nasal septum  15. 5. Segmented neutrophils, % 
8. 4. Bronchial asthma in mother   
 
x1y1r
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  Figure 1. The pair regression model [13. TSLP] and [2. Atopic dermatitis]            Figure 2. The pair regression model [13. TSLP] and [8. Domestic dust] 
 
In Figure 1, there is a model of matched regression that defines the relationship between the explained factor [13. TSLP] and the regressor 
[2. Atopic dermatitis]. The straight line defines the relationship between the explained factor and the regressor. The points designate the 
experimental data, received after clinical research. As it was mentioned above, enhancement of the severity of the disease leads to an 
increase in TLSP level. In the works of Ziegler and Artis, the relationship between [13. TSLP] factor and [2. Atopic dermatitis] regressor is 
defined, however, quantitative characteristics are not considered [30]. The real work complements the research conducted in [30], by 
quantitative relation. Presence of the sign [2. Atopic dermatitis] increases the possibility of bronchial asthma occurrence. This relation is 
portrayed in Figure 1. The correlation coefficient of the factor [2. Atopic dermatitis] and the explained factor is 0.37 [Table 3] which implies 
a weak relation. The average value of [13. TSLP] in case of the absence of the sign [2. Atopic dermatitis] is 23 pg/mL and 72 pg/mL ([2. 
Atopic dermatitis]=1) in case of its presence. Despite the fact that the presence of the sign [2. Atopic dermatitis] leads to an increase of 
the factor [13. TSLP] by 40, a low number of patients who have this sign allows to create, in the real work, only approximate model of 
matched regression that confirms the statement about stochastic increase of the factor [13. TSLP] in case of the presence of the sign [2. 
Atopic dermatitis], seen in [30]. 
In Figure 2, there is a model of matched regression, defining the relation between the explained factor [13. TSLP] and the regressor [8. 
Domestic dust]. The correlation coefficient between the explained factor [13. TSLP] and the regressor [8. Domestic dust] is 0,28 [Table 3] 
that assumes a weak relation. Learning the dependence of the values of factor [13. TSLP] on the value of the regressor [8. Domestic 
dust], the values of the explained factor [13. TSLP] were determined (7,0-21,0 pg/mL) at which the skin test in the conducted clinical 
research is considered weakly positive ([8. Domestic dust]=1 or [8. Domestic dust]=2), in case of significant allergic reaction to this allergen 
([8.Domestic dust]=3 or [8.Domestic dust]=4) with maximal TSLP index 38,3 pg/mL. Conducted experimental research say about the 
tendency to increasing of [13. TSLP] depending on the severity of allergic reaction of factor [8. Domestic dust]. Shifting from one degree 
of severity of the factor [8. Domestic dust] to another leads to increasing of the prognostic rate of [13. TSLP] proportionally to the value of 
the coefficient of matched regression . The absence of the sign is defined by the value of the coefficient . 
In Figure 3, there is a model of matched regression that defines the dependence of explained factor [13. TSLP] on the regressor [4. 
Bronchial asthma in relatives of the second generation]. The correlation coefficient between the explained factor [13. TSLP] and the 
regressor [4. Bronchial asthma in relatives of the second generation] is 0,22 [Table 3] that assumes the presence of weak relation. On the 
basis of the analysis of clinical research, an assumption is made that the presence of the sign of the regressor for the considered sample 
leads to the value of the factor [13. TSLP] that is higher than 50 pg/mL. In case of absence of the sign that characterizes this regressor a 
prognostic value for [13. TSLP] is 21 pg/mL. 
 
1b 7,23= a 9,37=
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              Figure 3. The pair regression model [13. TSLP] and                              Figure 4. The pair regression model [1. Severe persistent] and [13. TSLP] 
         [4. Bronchial asthma in relatives of the second generation] 
 
In Figure 4, there is a model of matched regression defining the dependence of the explained factor [1. Severe persistent] on the regressor 
[13. TSLP]. The correlation coefficient between the explained factor and the regressor is 0,73 [Table 3] which implies a strong relation 
and confirms conclusions made in [16]. The correlation coefficient, in this case, is a few times greater than for regressors mentioned 
above [2. Atopic dermatitis], [8. Domestic dust], [4. Bronchial asthma in relatives of the second generation], that is an important result of 
the real work. The presence of a strong relationship allows us to say about the general qualitative tendency of the explained factors 
depending on the similar regressors. The analysis of the model of a matched regression allows defining a break-off value of the [13. TSLP] 
factor, at which we can claim about a high possibility of the presence of severe bronchial asthma. Brake-off value of the factor [13. TSLP] 
is 63 pg/mL. This model of a matched regression can be, at some point, interpreted as a probabilistic model for prognostication of the 
severity of bronchial asthma, thus the distribution function of random variable determining the value of the [13. TSLP] factor can be roughly 
written as 
 
On the basis of the distribution function, there was an important assumption made within the clinical experiment, that 
increase of [13. TSLP] by 10 pg/mL leads to an increase in the possibility of severe bronchial asthma by 10%. 
 
                    
         Figure 5. The pair regression model [1. Severe persistent] and                              Figure 6. The pair regression model [1. Severe persistent] and  
                                            [2. Allergic rhinitis]                                                                                                      [8. Pillow feather]  
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In Figure 5, there is a model regression that determines the dependence of the explained factor [1. Severe persistent] on the regressor 
[2. Allergic rhinitis]. The correlation coefficient between the explained factor and the regressor is 0.3 (Table 3), which tells us about a low 
dependence and confirms conclusions made in [16]. In case of the absence of this factor in the history of the disease (the disease ([2. 
Allergic rhinitis]=1)) an assumption based on the real work can be made that only 15% of the children may develop severe bronchial 
asthma. The absence of the factor ([2. Allergic rhinitis]=0) doesn’t exclude the possibility of severe bronchial asthma development. 
In conclusion, we will analyze the regressive model that determines the dependence of the explained factor [1. Severe persistent] on the 
regressor [8. Pillow feather]. The regressor is coded with numbers: 0– absence of the sign, 1 and 2 – weakly positive, 3 and 4 – positive. 
In the conducted research, the regressor accepted values in the interval [0;4]. If the value of the regressor [8. Pillow feather]=3, then the 
prognostic value for the explained factor is 0.45. It’s assumed that if [8. Pillow feather]=4 then the value of the explained factor will probably 
surpass 0.5. 
 
Conclusion 
In this work, the complex of models pair regression for determining the severity of bronchial asthma was presented. The main provisions 
used for creating the complex of models regression were determined and substantiated. The premises were used, that a random error in 
the equation of regression is submitted to the normal distribution law, and the values of the factors determined after examination of every 
patient were received with the same accuracy. It made it possible to elaborate the way of assessment of the risk for the development of 
severe bronchial asthma in children and identify 15 factors that affect severe bronchial asthma. It was shown that the regressors chosen 
for the analysis are weakly linked to the explained factors, which makes it possible to determine only qualitative dependence between 
them. The analysis of factor thymic stromal lymphopoietin [13. TSLP] confirms the conclusions [21-23, 29], that it’s the most prominent 
indicator for the assessment of the severity of bronchial asthma. The correlation coefficient between [1. Severe persistent] and the 
regressor [13. TSLP] is 0,77 that implies a strong dependence between them. The analysis of the model of matched regression made it 
possible to identify a border value of the factor [13. TSLP], surpassing of which is considered as a high possibility for the presence of 
severe bronchial asthma. The increase of the factor [13. TSLP] by 10 pg/mL is considered as 10% higher possibility for severe bronchial 
asthma. 
These conclusions made it possible to formulate the perspectives for further studies. These studies are:  
a) construction and analysis of the model with two regressors that allows clarifying the results of the research; 
b) verification of the assumption that the values of the factors determined after examination of every patient have the same accuracy. 
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